Risks and consequences of travel burden on prophylactic granulocyte colony-stimulating factor administration and incidence of febrile neutropenia in an aged Medicare population.

MLA

Stephens, J.Mark, et al. “Risks and Consequences of Travel Burden on Prophylactic Granulocyte Colony-Stimulating Factor Administration and Incidence of Febrile Neutropenia in an Aged Medicare Population.” Current Medical Research & Opinion, vol. 35, no. 2, Feb. 2019, pp. 229–40. EBSCOhost, https://doi.org/10.1080/03007995.2018.1465906.

APA

Stephens, J. M., Bensink, M., Bowers, C., & Hollenbeak, C. S. (2019). Risks and consequences of travel burden on prophylactic granulocyte colony-stimulating factor administration and incidence of febrile neutropenia in an aged Medicare population. Current Medical Research & Opinion, 35(2), 229–240. https://doi.org/10.1080/03007995.2018.1465906

Chicago

Stephens, J. Mark, Mark Bensink, Charles Bowers, and Christopher S. Hollenbeak. 2019. “Risks and Consequences of Travel Burden on Prophylactic Granulocyte Colony-Stimulating Factor Administration and Incidence of Febrile Neutropenia in an Aged Medicare Population.” Current Medical Research & Opinion 35 (2): 229–40. doi:10.1080/03007995.2018.1465906.